Philips Korea and HoneyNaps Sign Sleep and Cardiovascular Health MOU
Philips Korea, part of Royal Philips, and HoneyNaps signed a memorandum of understanding on August 19 to explore healthcare opportunities linking sleep disorders and cardiovascular health, the companies announced in a press release.
The partnership will focus on integrating sleep data with cardiovascular risk factors. The companies also plan to examine possible work in cardiology and other cardiovascular disease areas.
Philips Korea brings sleep and respiratory care products, healthcare provider networks, and commercial capabilities. HoneyNaps provides AI powered sleep medicine tools, including FDA authorized technology for sleep disorder diagnosis and analysis.
The companies said the collaboration may also include academic initiatives related to sleep and cardiovascular health.
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from: Enterprise
More from: Life Sciences
Subscribe to Enterprise AI Brief
Weekly report on AI business applications, enterprise software releases, automation tools, and industry implementations.
Whitepaper
Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation
The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.
Read more